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development of asthma. 5 Evidence to support this is 
accumulating in animals and humans regarding ciga-
rette smoking. For example, animal experiments have 
shown that (1) offspring of mice exposed to cigarette 
smoke during pregnancy had lower expression of 
 The prevalence of asthma in childhood has increased over a relatively short period. 1 Consequently, 
although twin studies have indicated a strong genetic 
effect, environmental inﬂ uences are assumed to have 
a strong inﬂ uence. There is considerable evidence that 
gene-environment interactions may explain associa-
tions with both genetic and environmental inﬂ uences. 2 
Possible environmental exposures include tobacco 
smoke and other air pollutants. 2,3 Martino and Prescott 4 
stated that “epigenetic paradigms are the likely mech-
anism behind the environment-driven epidemic of 
asthma” and pointed to cigarette smoke as being an 
important component of such an environment. 
 One possible mechanism, combining environmental 
and genetic effects, is an epigenetic inﬂ uence on the 
 Background:  Animal data suggest that tobacco smoke exposure of a mother when she is in utero 
inﬂ uences DNA methylation patterns in her offspring and that there is an effect on the respira-
tory system, particularly airway responsiveness. The only study, to our knowledge, in humans 
suggests that there is a similar effect on asthma. The present study tests whether an association 
with respiratory problems can be conﬁ rmed in a large population study and aims to determine 
whether in utero exposure of the father has similar effects on his offspring. 
 Methods:  Information from the Avon Longitudinal Study of Parents and Children was used to com-
pare the offspring of women and of men who had themselves been exposed to cigarette smoke 
in utero; separate analyses were performed for children of women smokers and nonsmokers. The 
outcome measures were trajectories of history of early wheezing, doctor-diagnosed asthma by 
age 7 years, and results of lung function and methacholine challenge tests at 8 years. A variety 
of social and environmental factors were taken into account; offspring sexes were examined 
separately. 
 Results:  There was no association with any outcome in relation to maternal prenatal exposure. 
There was some evidence of an increase in asthma risk with paternal prenatal exposure when the 
study mother was a nonsmoker (adjusted OR, 1.17; 95% CI, 0.97-1.41). This was particularly 
strong for girls (adjusted OR, 1.39; 95% CI, 1.04-1.86). 
 Conclusions:  We did not ﬁ nd that maternal prenatal exposure to her mother’s smoking had any 
effect on her children’s respiratory outcomes. There was suggestive evidence of paternal prena-
tal exposure being associated with asthma and persistent wheezing in the granddaughters. 
  CHEST 2014; 145(6):1213–1218 
 Abbreviations: ALSPAC  5 Avon Longitudinal Study of Parents and Children; AOR  5 adjusted OR; M  5 mother; 
MGM  5 maternal grandmother;  2  5 did not smoke during pregnancy; PGM  5 paternal grandmother;  1  5 smoked 
during pregnancy 
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Wnt genes 6 and of other genes involved in lung devel-
opment 7 ; (2) rats developed emphysematous lesions 
in their lungs in association with their grandmothers’ 
exposure to nicotine when pregnant, regardless of 
whether this was via maternal or paternal prenatal 
expo sure 8 ; and (3) prenatal exposure of rats to nico-
tine resulted in reduced expression of peroxisome 
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 Materials and Methods 
 The data used in these analyses were collected as part of the 
ALSPAC, which was designed to assess the ways in which the 
environment interacts with the genotype to inﬂ uence health and 
development. 15 Pregnant women, resident in the study area in 
southwest England with an expected date of delivery between 
April 1, 1991 and December 31, 1992, were invited to take part. 
About 80% of the eligible population did so. 16 Ethical approval for 
the study was obtained from the ALSPAC Law and Ethics Com-
mittee and the Local Research Ethics Committees . 
 Information collected from the parents during their study preg-
nancy included details of the maternal and paternal grandmothers. 
In this study we investigated the two pathways of possible inﬂ u-
ence of parental prenatal exposure to cigarette smoke on the study 
child. 
 The women and their partners were sent six questionnaires 
during pregnancy (e-Appendix 1; full details can be found on the 
study website http://www.bristol.ac.uk/alspac/researchers/data-
access/data-dictionary/). Questions elicited information on their 
current smoking habits and those of their parents (ie, the study 
grandparents). If the parents had reported that their mothers had 
smoked, they were asked whether their mothers had smoked 
when they were pregnant with them—and, if so, were given the 
responses yes/no/don’t know from which to select. Thus, the par-
ents who replied “don’t know” had a mother who smoked, but the 
parent was unsure whether she had smoked during her pregnancy. 
We have analyzed these data in two ways: (1) assuming that all 
these women did smoke during pregnancy and (2) omitting the 
“don’t knows” from the analyses and only analyzing those deﬁ -
nitely reporting smoking status during the study pregnancy (this 
we have treated as a sensitivity analysis). 
 Since maternal smoking in pregnancy has a well-demonstrated 
effect on the child’s respiratory system, 17 we have analyzed mothers 
who themselves smoked during the study pregnancy separately 
from those who did not (smoked during pregnancy [ 1 ], did not 
smoke during pregnancy [ 2 ]). Consequently, we compare four 
groups of grandchildren: those whose grandmothers (maternal 
grandmothers [MGMs] and paternal grandmothers [PGMs]) 
smoked during the pregnancy resulting in their parent but whose 
mothers (Ms) had not smoked (MGM 1 M 2 with MGM 2 M 2 
and PGM 1 M 2 with PGM 2 M 2 ) and similar comparisons where 
the study mother herself smoked (MGM 1 M 1 with MGM 2 M 1 
and PGM 1 M 1 with PGM 2 M 1 ). 
 Several different outcomes of respiratory function were used 
in this study: 
 1. The mother’s report of doctor-diagnosed asthma ever in her 
study child at age 7 to 8 years  in association with a history of 
wheezing in the preceding 12 months. 
 2. Three mutually exclusive trajectories of wheezing symptoms 
between the ages of 6 and 42 months, classiﬁ ed as early-onset 
transient (onset before 18 months but clear at 42 months), 
late onset (ie, no wheezing prior to 18 months, but present 
at 42 months), and early-onset persistent, persistent being 
deﬁ ned as onset before 18 months and present at 42 months. 18 
 3. Lung function measured by spirometry (Vitalograph 2120; 
Vitalograph) at age 8 to 9 years according to American Tho-
racic Society criteria. 19 Flow-volume curves were reviewed 
by one respiratory physician (J. H.) to ensure adherence to 
standards, resulting in the rejection of 338 measurements 
(4.6%) and the correction of 883 (11.5%), where the auto-
mated program had selected an inappropriate curve. Each 
variable (FEV 1 , FVC, and maximal forced expiratory ﬂ ow, 
midexpiratory phase) was converted to sex-, age-, and height-
adjusted SD units using plots of residuals from multiple 
linear regression of lung function with sex, age, and height in 
proliferator-activated receptor- g in the respiratory 
sys tem of the offspring and in changes in respiratory 
responses to methacholine challenge; there were sex-
speciﬁ c effects, with male offspring exhibiting increased 
effects. The next generation also had the same response 
to methacholine challenges even though they had not 
been exposed to nicotine in utero themselves. 9 In 
humans (1) Breton and colleagues 10 showed speciﬁ c 
methylation patterns of children whose mothers had 
smoked during pregnancy; (2) Murphy and colleagues 11 
showed that exposure to maternal smoking in utero 
was associated with greater methylation levels at the 
 IGF2 gene region, especially in boys; and (3) a genom-
ewide study of 1,062 newborn infants showed differ-
ences in methylation patterns among those prenatally 
exposed; these involved  CYP1A1 ,  GFI1 , and  AHRR , 
with results that have been replicated in another 
cohort. 12 
 The transgenerational ﬁ ndings in rats 8,9 raise the 
question as to whether there are similar intergenera-
tional effects on human respiratory responses. One 
much-quoted study published in 2005 indicated that 
childhood asthma was inﬂ uenced not only by prena-
tal smoking by the mother but also by the exposure of 
the mother in utero to her own mother’s smoking. 13 
We have been unable to identify any other human 
studies examining the grandmaternal history of smok-
ing in the mother’s pregnancy regarding asthma or 
lung development in her offspring. We have, therefore, 
analyzed the information from the population-based 
Avon Longitudinal Study of Parents and Chil dren 
(ALSPAC) in an attempt to replicate the associations 
of Li and colleagues. 13 Various studies have shown a 
male-speciﬁ c effect of exposure to smoking/nicotine 
in utero on development 9,14 and on gene methylation 9,11 
in the offspring; we, therefore, hypothesized that effects 
would be more apparent in boys than girls. Thus, our 
primary aims were to test whether the maternal or 
paternal grandmother’s prenatal smoking has an effect 
on measures relating to asthma and whether any effect 
is sex-speciﬁ c. 
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nancy (ie, MGM 1 M 1 vs MGM 2 M 1 and PGM 1 M 1 
vs PGM 2 M 1 ). There is no evidence to suggest that 
prenatal exposure of the study mother or of the 
study father to cigarette smoke affected the likeli-
hood of the study child being diagnosed with asthma. 
Similar lack of association was found for boys and for 
girls when analyzed separately. For children whose 
mothers did not smoke during pregnancy (MGM 1 M 2 
vs MGM 2 M 2 and PGM 1 M 2 vs PGM 2 M 2 ) 
( Table 2 ), there was a similar lack of evidence of an 
association with maternal prenatal exposure, but there 
was weak evidence of an association with paternal pre-
natal exposure (OR, 1.20; 95% CI, 1.00-1.43) that atten-
uated after adjustment (OR, 1.17; 95% CI, 0.97-1.41). 
When boys and girls were considered separately, there 
was stronger evidence for an association between 
paternal prenatal exposure (PGM 1 ) and asthma in 
girls (adjusted OR [AOR]  5 1.39; 95% CI, 1.04-1.86) 
than boys (AOR  5 1.04; 95% CI, 0.81-1.34) ( P inter-
action  5 .111). 
 Three different wheezing trajectories to age 
42 months were considered: early-onset persistent, 
early-onset transient, and late onset. The only sugges-
tion of an association with parental prenatal exposure 
was for persistent wheezers whose mothers did not 
smoke during the index pregnancy (e-Tables 1-12). 
Pater nal prenatal exposure (PGM 1 ) was associated with 
persistent wheezing in girls, (unadjusted OR  5 1.60; 
95% CI, 1.01-2.53; AOR  5 1.42; 95% CI, 0.86-2.36]) 
(e-Table 9 ). Maternal prenatal exposure (MGM 1 ) 
was associated with persistent wheezing (unadjusted 
OR  5 1.41; 95% CI, 1.09-1.82), but this attenuated 
on adjustment (AOR  5 1.26; 95% CI, 0.95-1.67); 
there was little difference in effect sizes between boys 
and girls (e-Tables 10-12). There were no consistent 
relationships between parental prenatal exposure 
(MGM 1 or PGM 1 ) and any measure of lung func-
tion (e-Tables 1-12). 
 Discussion 
 Using a large population study with detail on both 
maternal and grandmaternal smoking behavior during 
pregnancy, we have not found that maternal prenatal 
exposure (MGM 1 ) to tobacco smoke has an adverse 
effect on her offspring’s risk of respiratory symptoms 
or lung function during early childhood. In contrast, 
we have shown that prenatal tobacco smoke exposure 
of fathers (PGM 1 ) was associated with an increased 
risk of persistent wheeze in early childhood and asthma 
by age 7 years in daughters of nonsmoking mothers 
in this population. However, there was little evidence 
of deleterious transgenerational effects of parental 
prenatal exposure on any objective measures of lung 
function, including bronchial responsiveness. 
the ALSPAC cohort using the method described by Chinn 
and Rona. 20 
 4. Airway responsiveness to methacholine was measured using 
the method of Yan et al. 21 Brieﬂ y, this involved using precali-
brated, hand-held glass nebulizers (DeVilbiss No. 40; DeVilbiss 
Healthcare LLC) to deliver cumulative doubling doses of 
methacholine solution from approximately 0.03  m mol to a 
maximum dose of 4  m mol in eight steps at 1-min intervals. 
FEV 1 was measured 1 min after the previous dose (just 
prior to the subsequent dose delivery), and the test was con-
tinued until FEV 1 declined by  . 20% from baseline or the 
maximum dose was given. FEV 1 was plotted against cumula-
tive dose of methacholine, and a regression was ﬁ tted by least 
sum of squares to derive the dose-response slope (percent 
decline of FEV 1 per  m mol methacholine) expressed for 
each subject. The intercept of this slope with a 20% reduc-
tion from baseline FEV 1 is equivalent to the provoking dose 
causing a 20% fall in FEV 1 of FEV 1 (percentage decline 
from baseline) per  m mol methacholine for subjects who 
responded to bronchial challenge. Dose-response slopes 
were categorized as zero response or one of three tertiles 
of the distribution of non-zero slopes (mild, moderate, or 
severe airway responsiveness), each of which was catego-
rized as % fall in FEV 1 from baseline per  m mol of metha-
choline (greater value  5 more responsive); mild was deﬁ ned 
as   0.815, moderate from 0.816 to 2.384, and severe as 
  2.385 (the severe tertile being equivalent to a provoking 
dose causing a 20% fall in FEV 1   8.4  m mol). 
 5. Other data used in the analyses include the study mother’s 
parity (ascertained from the maternal report of previous 
pregnancies resulting in either a live or stillbirth, and coded 
as 0; 1 1 ); gestation (completed weeks: 39 1 ; 37-38;   36); 
mother’s partner smoking in pregnancy (primarily reported 
by partner, but maternal report was used if missing: yes, no); 
maternal age at the birth of the child (continuous); housing 
tenure as a measure of socioeconomic background (owned 
or mortgaged, rented public housing, all other); maternal 
education (highest level of educational attainment, in ﬁ ve 
levels of increasing achievement); whether the child was 
breastfed family history of asthma, defined as history in 
either parent at the time of the pregnancy; and the exposure 
of the child to environmental tobacco smoke at two time 
points (age 0-2 years and 2-8 years) measured as whether 
the child had been present in a room with someone smoking. 
For comparisons of MGM 1 M 1 with MGM 2 M 1 , and 
of PGM 1 M 1 with PGM 2 M 1 , the amount the mother 
smoked in pregnancy (grouped as 1-9, 10-19, 20 1 ciga-
rettes per day) was taken into account. 
 The data were analyzed using logistic regression for binary data 
(eg, diagnosed asthma) and using multiple regression for contin-
uous scales (eg, measures of lung function). The analyses were 
undertaken in four stages. First, the unadjusted associations are 
given. Model I then adjusts for family history of asthma; model II 
additionally adjusts for gestation, parity, maternal education, breast-
feeding, and the amount the mother smoked during pregnancy; 
model III additionally adjusts for paternal smoking in pregnancy 
and exposure of the child to environmental tobacco smoke at 
two time points. The analyses were repeated for boys and girls 
separately. 
 Results 
 The results of the analyses for each of the pairs of 
grandmaternal smoking history are shown in  Table 1 
for the mothers who themselves smoked in preg-
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in a beneﬁ cial effect on her male offspring’s birth-
weight but only if she was a nonsmoker herself 
(L. L. Miller, MSc; M. Pembrey, MD; G. Davey 
Smith, MD; K. Northstone, PhD; J. Golding, PhD; 
unpublished data, 2013). Conversely, here we ﬁ nd 
 We failed to replicate the associations between 
the maternal prenatal smoking exposure and respira-
tory outcomes reported by Li and colleagues. 13 We 
have previously shown that maternal exposure in 
utero to her own mother’s smoking (MGM 1 ) resulted 
 Table 1— Risk of Doctor-Diagnosed Asthma by Age 7 y Among Children Whose Mothers Smoked 
During Pregnancy, According to Whether the Grandmother Smoked During the Pregnancy Resulting in the Parent 
of the Study Child 
Statistical Models a PGM 1 M 1 vs PGM 2 M 1 MGM 1 M 1 vs MGM 2 M 1 
Boys and girls
 No. 88 of 507 (PGM 1 M 1 ), 94 of 540 (PGM 2 M 1 ) 112 of 655 (MGM 1 M 1 ), 126 of 770 (MGM 2 M 1 )
 Unadjusted 1.00 (0.72-1.37) 1.05 (0.80-1.39)
 Model I 1.02 (0.73-1.41) 1.05 (0.79-1.39)
 Model II 0.99 (0.69-1.40) 1.09 (0.79-1.50)
 Model III 0.94 (0.65-1.34) 1.08 (0.78-1.51)
Boys only
 No. 51 of 252 (PGM 1 M 1 ), 50 of 279 (PGM 2 M 1 )  65 of 348 (MGM 1 M 1 ), 70 of 389 (MGM 2 M 1 )
 Unadjusted 1.16 (0.75-1.79) 1.05 (0.72-1.52)
 Model I 1.19 (0.76-1.85) 1.02 (0.69-1.49)
 Model II 1.18 (0.73-1.90) 1.12 (0.73-1.72)
 Model III 1.07 (0.65-1.76) 1.10 (0.71-1.72)
Girls only
 No. 37 of 255 (PGM 1 M 1 ), 44 of 261 (PGM 2 M 1 ) 47 of 307 (MGM 1 M 1 ), 56 of 381 (MGM 2 M 1 )
 Unadjusted 0.84 (0.52-1.35) 1.05 (0.69-1.60)
 Model I 0.84 (0.52-1.37) 1.09 (0.71-1.68)
 Model II 0.86 (0.51-1.46) 1.05 (0.65-1.71)
 Model III 0.84 (0.49-1.44) 1.07 (0.64-1.78)
Data shown are OR with 95% CI using the nonsmoking grandparents as the reference. M  5 mother; MGM  5 maternal grandmother;  2  5 did not 
smoke during pregnancy; PGM  5 paternal grandmother;  1  5 smoked during pregnancy.
 a No. indicates the proportion of children who were given the diagnosis of asthma. Model I adjusts for family history of asthma; Model II additionally 
adjusts for gestation, parity, maternal education, breastfeeding, and the amount the mother smoked during pregnancy; Model III, in addition, 
adjusted for paternal smoking in pregnancy and exposure of the child to environmental tobacco smoke at two time points.
 Table 2— Risk of Doctor-Diagnosed Asthma by Age 7 y Among Children Whose Mothers Did Not Smoke 
During Pregnancy, According to Whether the Grandmother Smoked During the Pregnancy Resulting in the Parent 
of the Study Child 
Statistical Models a PGM 1 M 2 vs PGM 2 M 2 MGM 1 M 2 vs MGM 2 M 2 
Boys and girls
 No. 244 of 1,723 (PGM 1 M 2 ), 346 of 2,855 (PGM 2 M 2 ) 231 of 1,689 (MGM 1 M 2 ), 497 of 3,767 (MGM 2 M 2 )
 Unadjusted 1.20 (1.00-1.43) b 1.04 (0.88-1.23)
 Model I 1.23 (1.02-1.47) b 1.07 (0.90-1.26)
 Model II 1.17 (0.97-1.41) 1.02 (0.85-1.22)
 Model III 1.17 (0.97-1.41) 1.01 (0.84-1.22)
Boys only
 No. 133 of 854 (PGM 1 M 2 ), 221 of 1,477 (PGM 2 M 2 ) 138 of 853 (MGM 1 M 2 ), 302 of 1,931 (MGM 2 M 2 )
 Unadjusted 1.05 (0.83-1.32) 1.04 (0.84-1.30)
 Model I 1.09 (0.86-1.38) 1.09 (0.87-1.36)
 Model II 1.04 (0.81-1.34) 1.02 (0.81-1.30)
 Model III 1.04 (0.81-1.34) 1.01 (0.79-1.28)
Girls only
 No. 111 of 869 (PGM 1 M 2 ), 125 of 1,378 (PGM 2 M 2 ) 93 of 836 (MGM 1 M 2 ), 195 of 1,836 (MGM 2 M 2 )
 Unadjusted 1.47 (1.12-1.92) b 1.05 (0.81-1.37)
 Model I 1.48 (1.12-1.95) b 1.05 (0.80-1.37)
 Model II 1.40 (1.05-1.87) b 1.01 (0.76-1.33)
 Model III 1.39 (1.04-1.86) b 1.03 (0.77-1.37)
Data shown are OR with 95% CI using the nonsmoking grandparents as the reference. See Table 1 legend for expansion of abbreviations.
 a No. indicates the proportion of children who were given the diagnosis of asthma. Model I adjusts for family history of asthma; Model II additionally 
adjusts for gestation, parity, maternal education and breastfeeding; Model III, in addition, adjusted for paternal smoking in pregnancy and exposure 
of the child to environmental tobacco smoke at two time points.
 b Result is statistically signiﬁ cant.
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natal smoke exposure may be more important than 
maternal prenatal smoke exposure in determining the 
risk of transgenerational effects. Indeed, if the mech-
anism operates through epigenetic mechanisms, there 
is evidence that epigenetic consequences of prenatal 
exposure may be more evident in male than female 
offspring. 11  
 There are a number of key strengths in this study: 
(1) the data on grandmaternal smoking in pregnancy 
were ascertained from the parents during the study 
pregnancy, prior to the birth of the study child, and, 
thus, are not biased by identiﬁ cation of respiratory 
outcomes; (2) data on respiratory outcomes were col-
lected using different methods, including maternal 
reports asked at various time points, and objective mea-
surements of lung function and bronchial responsive-
ness to methacholine; and (3) the number of subjects 
with available data were large, enabling a detailed 
analysis of different exposure subgroups deﬁ ned a 
priori. 
 Nevertheless, there are potential difﬁ culties with 
this study: (1) we relied on parental reporting of their 
mothers’ smoking habit, which was subject to report-
ing bias. However, the study method of obtaining 
information using postal questionnaires allowed time 
for each parent to acquire the relevant answer from 
members of their family. (2) As with all observational 
studies, there is the possibility that all appropriate 
confounders have not been taken into account and 
residual confounding exists. 
 Conclusions 
 We found no association between asthma risk and 
maternal exposure in utero; however, sex-speciﬁ c anal-
ysis did indicate that paternal exposure to his mother 
smoking during pregnancy was associated with a 
higher asthma risk in his daughters. These results 
should be regarded as hypothesis-generating only, 
being dependent just on reported symptoms without 
corroborating biologic evidence. 
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that there are no convincing effects of maternal pre-
natal exposure on signs of the offsprings’ respiratory 
symptoms or measurements. We considered the rela-
tionship for boys and girls separately and for mothers 
who smoked in the study pregnancy compared with 
those who did not, but found no consistent relation-
ships. There were a number of differences between 
the two studies that may possibly explain this. 
 1. The numbers in the study by Li and colleagues 13 
were smaller (279 cases, 412 control subjects) 
compared with the present study (966 cases of 
asthma, 5,915 without asthma). 
 2. The study by Li and colleagues 13 adjusted only 
for gestation, passive smoking, and race; the 
present study comprised 96% white children; 
analyses adjusted for gestation, passive smok-
ing, family history of asthma, parity, maternal 
education, paternal smoking in pregnancy, and, 
for smoking mothers, the amount the mother 
smoked. The latter was particularly important, 
as mothers whose own mother smoked during 
pregnancy are more likely to be heavy smokers 
themselves. 22 
 3. The background environment, and, hence, the 
inﬂ uence on the development of asthma, is likely 
to have differed substantially between Southern 
California and England and may conceivably have 
been responsible for the differences between 
the ﬁ ndings in the two studies. 
 4. We think it unlikely, but not impossible, that a 
difference in the ages studied may have been rel-
evant: the study by Li and colleagues 13 was con-
cerned with asthma in the ﬁ rst 5 years, whereas 
our study was concerned with asthma diagnosed 
by 7 to 8 years of age. 
 It is of relevance to note that the wheezing trajec-
tory analysis, which considers only the ﬁ rst 42 months, 
did show an association between maternal in utero 
exposure and persistent wheezing, although this asso-
ciation was attenuated on full adjustment for age, 
education level and parity of the mother, paternal smok-
ing, housing tenure, whether the child was breastfed, 
parental history of asthma, and exposure of the child to 
environmental tobacco smoke, and also, if the mother 
smoked in pregnancy, the amount smoked. 
 There have been a number of studies that have indi-
cated more extreme effects of prenatal smoke expo-
sure on the developing boy compared with the girl; 
these include a greater association with intrauterine 
growth 14,23 and congenital defects. 24,25 Additionally, 
prenatal exposure to nicotine can interfere with the 
development of the male gonadal axis and with the 
organization of sexually dimorphic behavior. 26 It is 
conceivable that the adverse effects of paternal pre-
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